Recent research has raised concerns about weight loss injections like semaglutide (sold as Ozempic and Wegovy), revealing a potential link to a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). People with diabetes on semaglutide were four times more likely to develop NAION, and those who were overweight or obese faced a sevenfold higher risk compared to other weight loss medications. The condition, often termed an 'eye stroke', can cause sudden vision loss in one eye without pain, and there's currently no effective treatment. Despite its benefits for weight management and diabetes, the safety of these injections is now under scrutiny, urging caution among users and medical professionals alike.
As reported by Dailymail, slimmers were cautioned today that weight loss needles could cause a serious eye problem that could lead to blindness.
Semaglutide, marketed as Ozempic and Wegovy, has been heralded as a game changer in the fight against o...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
